Massachusetts H2472 aims to protect patient safety by regulating the distribution of non-FDA approved compounded medications.

Massachusetts H2472 establishes regulations for the distribution of compounded medications, which are not approved by the FDA. The bill mandates that compounded medications must include detailed ingredient lists and adverse event reporting information. It prohibits retail pharmacies from reselling compounded medications and requires that these medications be dispensed only to the patient for whom they were originally compounded. The bill also specifies that compounded drugs labeled "office use only" must be administered in the office and not dispensed to patients.

Massachusetts H2472 aims to protect patient safety by regulating the distribution of non-FDA approved compounded medications.

Massachusetts H2472 establishes regulations for the distribution of compounded medications, which are not approved by the FDA. The bill mandates that compounded medications must include detailed ingredient lists and adverse event reporting information. It prohibits retail pharmacies from reselling compounded medications and requires that these medications be dispensed only to the patient for whom they were originally compounded. The bill also specifies that compounded drugs labeled "office use only" must be administered in the office and not dispensed to patients.